Revenue Growth
Revenue came in at $9.645 billion, up 8% on the prior year. EBITDA also increased by 8% to $1.725 billion, with a net profit of $514 million, up 7%.
Strong Cash Generation
Cash generation was just shy of $1.3 billion, demonstrating strong operational cash flow.
Positive Outlook for FY 2026
Guidance for FY 2026 indicates EBITDA growth of up to 13% on FY 2025, equating to about 16% growth using current exchange rates.
Strategic Acquisitions
Successful acquisitions in Switzerland and Germany, particularly the LADR acquisition, are expected to drive future growth.
New Contracts and Expansions
Secured new contracts in the U.S. and Australia, including a major payer contract in New Jersey and hospital contracts in Australia.